Is Nutra Pharma Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Nutra Pharma Corp (NPHC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nutra Pharma Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nutra Pharma Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Nutra Pharma Corp?

Muslim investors may consider investing in Nutra Pharma Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nutra Pharma Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Nutra Pharma Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nutra Pharma Corp updated?

The Shariah compliance status of Nutra Pharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nutra Pharma Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nutra Pharma Corp?

You can check the latest Shariah compliance status of Nutra Pharma Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Nutra Pharma Corp. Stock Analysis NPHC

United States Health Care Nano Cap

Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Plantation, Florida and currently employs 6 full-time employees. The company went IPO on 2001-10-09. The firm's drug candidates include RPI-MN and RPI-78M. RPI-MN is used to treat neurological diseases and autoimmune diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease), Rheumatoid Arthritis (RA) and Myasthenia Gravis. The RPI-78M is used to treat viral diseases, including HIV/AIDS and Herpes. The firm offers Nyloxin/Nyloxin Extra Strength as its over-the-counter (OTC) pain reliever. The company is focused upon marketing homeopathic drugs for the treatment of pain: Nyloxin, Nyloxin Extra Strength Pet Pain, Equine Pain, and Luxury Feet.

Key Statistics of Nutra Pharma Corp (NPHC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

14.28M

P/E Ratio (TTM)

52 Week Range

$0.00$0.01

Market Cap

2.15M

Avg. Volume

1.67M

Dividend Yield

Financial Metrics & Statements of Nutra Pharma Corp (NPHC)

FAQ's for Nutra Pharma Corp (NPHC)

According to Musaffa’s Shariah screening methodology, Nutra Pharma Corp (NPHC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.